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Background and purpose: Ischemic postconditioning has been demonstrated to be a protective procedure to
brain damage caused by transient focal ischemia/reperfusion. However, it is elusive whether the protection of
postconditioning against brain damage and neuroinflammation is via regulating TLR2 and TLR4 pathways. In the
present study, we examined the protection of ischemic postconditioning performed immediately prior to the
recovery of cerebral blood supply on brain damage caused by various duration of ischemia and tested the
hypothesis that its protection is via inhibition of neuroinflammation by modulating TLR2/TLR4 pathways.
Methods: Brain damage in rats was induced by using the middle cerebral artery occlusion (MCAO) model. Ischemic
postconditioning consisting of fivecycles of ten seconds of ischemia and reperfusion was performed immediately
following theischemic episode Theduration of administration of ischemic postconditioning was examined by
comparing its effects on infarction volume, cerebral edema and neurological function in 2, 3, 4, 4.5and 6 hour
ischemia groups. The protective mechanism of ischemic postconditioning was investigated by comparing its
effects on apoptosis, production of the neurotoxic cytokine IL-1β and the transcription and expression of TLR2,
TLR4 and IRAK4 in the 2 and 4.5 hour ischemia groups.
Results: Ischemic postconditioning significantly attenuated cerebral infarction, cerebral edema and neurological
dysfunction in ischemia groups of up to 4 hours duration, but not in 4.5and 6 hour ischemia groups. It also
inhibited apoptosis, production of IL-1β, abnormal transcription and expression of TLR2, TLR4 and IRAK4 in the
2 hour ischemia group, but not in the 4.5 hour ischemia group.
Conclusions: Ischemic postconditioning protected brain damage caused by 2, 3 and 4 hours of ischemia, but not
by 4.5 and 6 hours of ischemia. The protection of ischemic postconditioning is associated with its inhibition of
neuroinflammation via inhibition of TLR2 and TLR4 pathways.
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Cerebral damage due to reperfusion following ischemia
has been proven to be an important factor affecting the
prognosis of revascularization of occluded blood vessels
[1]. Thus, many researchers focus on developing new
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stated.ischemia and reperfusion. Recently, accumulating evi-
dence from animal studies and clinical trials has shown
that ischemic postconditioning is an effective procedure
to suppress secondary tissue injury following recovery of
blood supply. Ischemic postconditioning is defined as a
series of rapid intermittent interruptions of blood flow
in the early phase of reperfusion that mechanically alters
the hydrodynamics of reperfusion [2]. Ischemic postcon-
ditioning has been found to protect ischemia/reperfu-
sion-induced tissue injury in brain, as well as in heart,td. This is an Open Access article distributed under the terms of the Creative
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respectively have reported that ischemic postcondition-
ing protected rat cerebral injury caused by reperfusion
following either global ischemia or focal ischemia [6,7].
Therefore, ischemic postconditioning, as an emerging
protective method, might be used clinically to prevent tis-
sue damage caused by reperfusion due to revascularization
of occluded blood vessels.
TLRs (Toll-like receptors) are the main signal pathways
responsible for regulating endogenous or exogenous in-
flammation [8]. Neuroinflammation mediated by TLR2 or
TLR4 was proved to play an active role in aggravating
brain damage caused by ischemia/reperfusion. Under is-
chemic stimuli, TLR2 and TLR4 are both found to be
expressed on neurons and glial cells such as microglia and
astrocytes and would be activated when they are attached
to their corresponding ligands such as heat-shock proteins
(HSPs) and high mobility group box 1 (HMGB1) [9]. By
contrast, inhibition of TLR2 or TLR4 pathway was re-
ported to produce neuroprotection. Lehnardt et al. found
that TLR2-deficient mice develop a decreased CNS injury
compared to wild type mice insulted by focal cerebral
ischemia [10]. Similarly, Ahmad et al. found that the ex-
pressional levels of neurotoxic cytokines TNF-α and IL-1β
induced by traumatic brain injury was mitigated in TLR4
knockout mice [11]. Therefore, these studies showed that
inhibition of TLR2- or TLR4- mediated neuroinflamma-
tion would exert protection on ischemia/reperfusion-in-
duced brain damage.
Recently, ischemic postconditioning has been found
to inhibit ischemia/reperfusion-induced inflammation
in brain, heart, lung and liver [12-14]. Kong et al. reported
that ischemic postconditioning suppressed the abnormal
expression of inflammation mediators such as IL-1β and
IL-6 caused by cerebral ischemia and reperfusion [15]. Joo
et al. showed that the protection of ischemic postcondi-
tioning was associated with inhibition of the reduction in
immune cell numbers in the peripheral blood caused by
cerebral ischemia/reperfusion [11]. Also, Wu et al. found
that ischemic postconditioning reduced post-ischemic
release of the cytokines TNF -α and IL-8 [12]. Therefore,
it remains elusive as to whether the inhibitory effect of
ischemic postconditioning on inflammation is via modu-
lating the TLR2/TLR4 pathway. Additionally, despite the
effects of various ischemic postconditioning strategies that
have been studied widely, the time duration of ischemic
postconditioning treatment remains unclear. Thus, we
investigated these two issues in this study by using the rat
middle cerebral artery occlusion (MCAO) model.
Materials and methods
Animals
Adult male Sprague–Dawley rats (n = 104; weighing 280
to 300 g; seven to eight weeks of age), purchased fromChengdu Dashuo Biotechnological Company (Chengdu,
China), were housed in a temperature-controlled room
(22 to 25°C) on a 12-hour light/dark cycle with free
access to food and water. All animal procedures were ap-
proved by the ethical committee for animal experiments,
Kunming Medical University. All possible measures were
taken to reduce animal suffering and numbers of animals
in this study.Animal groups and surgical procedure
At the start of the study, the rats were randomly
assigned into a sham-operated group, an ischemia group
and an ischemic postconditioning group according to a
computer generated randomization schedule.
Cerebralischemia was produced by using the middle
cerebral artery occlusion (MCAO) model in rats as
previously described [7]. In brief, a surgical incision was
made to expose the right common carotid artery (CCA),
internal carotid artery and external carotid artery. The
proximal CCA then was ligated, and an occlusion filament
was inserted into the internal carotid artery through the
CCA 19 to 21 mm distal from the bifurcation to occlude
the origin of the middle cerebral artery (MCA). After
induction of ischemia, the filament was withdrawn and
the rats were placed into a cage to recover from anesthesia
at room temperature, with free access to food and drink.
The rats in the ischemia group were subjected to 2, 3,
4 h, 4.5, and 6 hours of focal cerebral ischemia. Ischemic
postconditioning was performed at the beginning of
reperfusion, and the ischemic postconditioning rats were
subjected to five cycles of ten seconds of clipping both
carotid arteries and tenseconds of reperfusion. In the
sham group, rats were subjected to the same procedures
except for occlusion of the MCA.Measurement of infarct volume and cerebral edema
At reperfusion at 48 hours, six rats from each group
were chosen randomly, decapitated and the brains were
rapidly removed. Brains were cut into 2-mm-thick coronal
sections and stained with 1% triphenyl tetrazolium
chloride (confirm) (TTC) solution for 30 minutes at
37°C followed by overnight immersion in 4% parafor-
maldehyde. The infarct volume and cerebral edema
were calculated as previously described [16] using the
formulae:
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Evaluation of neurological functional score
Neurological functional scores were evaluated at 48 hours
post reperfusion. The test consists of two aspects of
neurological function as has been previously described
[17]: (1) the postural reflex test to examine upper body
posture while the animal is suspended by the tail; (2) the
forelimb placing test to examine sensorimotor integration
in forelimb placing responses to visual, tactile, and pro-
prioceptive stimuli. Neurological function was graded on a
scale of 0 to 12 (normal score, 0; maximal score, 12).
Analysis of apoptosis by flow cytometry
At 48 hours post reperfusion, four rats from each group
were deeply anesthetized with chloral hydrate, and the
tissues from the infarcted cortex were collected and
maceratedmechanically in ice-cold PBS buffer before
being filtered with a 30 μm pore size nylon filter. After
the cellular number was adjusted to 1 × 106/ml, the cells
were centrifuged for ten minutes at 2,000 rpm, washed
three times with PBS and fixed for 30 minutes in 70%
ethanol. The fixed cells were washed three times with
PBS, and suspended in PBS containing 0.1% Triton
X-100 and 0.2% BSA at 37°C for 15 minutes, followed
by being washed with PBS containing 0.2% BSA. After
the cells had been incubated for one hour at 37°C with
30 μl FITC-dUTP (Roche Appiled Science, Mannheim,
Germany), they were treated with 20 μl RNAse (10 mg/ml)
at 37°C for 15 minutes and 500 μl of propidium iodide
(100 μg/ml) for 30 minutes in the dark. The cells were then
analyzed using flow cytometry (Beckman 4CR) and the rate
of apoptosis was analyzed using software WinCycle DNA
(Phoenix Flow Systems, San Diego, CA, USA).
Immunohistochemistry
At 48 hours post reperfusion, four rats from each group
were deeply anesthetized with chloral hydrate and
perfused transcardially with 0.9% saline, followed by 4%
paraformaldehyde in 0.1 mmol/L PBS. The brain was
removed, fixed overnight in 4% paraformaldehyde in
0.1 M PBS, dehydrated in a graded series of alcohols,
and embedded in paraffin. The embedded brains were
then cut coronally into 4 μm-thick sections, incubated
overnight at 4°C with 1:100 rabbit anti-TLR2 (Boster
Biotechnology Company, Wuhan, China) and 1:100 mouse
anti-TLR4 (Abcam, Cambridge, USA). Staining was de-
veloped with nickel-DAB solution (Maixin Biotech
Company, Fuzhou, China). The positive cells were countedunder a 400 × light microscope in five visual fields of
the ischemic cortex region of the infarcted area and
the images were captured by a digital camera connected
to a microscope (Olympus BX43, Japan).Double immunofluorescence staining
The paraffin-embedded brain was serially cut into
10 μm-thick sections in coronal plane. After the stand-
ard histological procedures, sections were incubated
overnight at 4°C in the mixture of 1:100 rabbit anti-
TLR2 (Boster Biotechnology Company, Wuhan, China)/
1:100 mouse anti-NeuN (Millipore Corporation, Billerica,
USA), 1:100 rabbit anti-TLR2/1:1,000 mouse anti-GFAP
(Millipore Corporation, Billerica, USA), 1:100 rabbit anti-
TLR2 (Boster Biotechnology Company, Wuhan, China),
1:100 rabbit anti-TLR4 (Boster Biotechnology Company,
Wuhan, China)/1:100 mouse anti-NeuN (Millipore Cor-
poration, Billerica, USA), 1:100 mouse anti-TLR4 (Abcam,
Cambridge, USA)/1:1,000 rabbit anti-GFAP (Millipore
Corporation, Billerica, USA), 1:100 mouse anti-TLR4
(Abcam, Cambridge, USA). Then the sections were incu-
bated respectively with 1:800 Alexa Fluor 568 donkey
anti-rabbit (Invitrogen Life Technologies, NY, USA), 1:300
Alexa Fluor 555 donkey anti-mouse (Beyotime) for one
hour at room temperature, followed incubated with 1:800
Alexa Fluor 488 donkey anti-mouse (Invitrogen Life
Technologies, NY, USA), 1:800 Alexa Fluor 488 donkey
anti-rabbit (Invitrogen Life Technologies, NY, USA), 1:100
Lectin-FITC conjugate (Sigma-Aldrich, St. Louis, USA) for
onehour at room temperature. Finally, these sections
were observed under laser confocal microscope (Leica,
Germany).Real-time PCR
At 48 hours post reperfusion, the tissues from the in-
farcted cortex of four rats in each group were collected
and the mRNA expressions of TLR2, TLR4, IRAK4 and
IL-1β were assayed by using real-time RT-PCR. In brief,
total RNA of infarcted cortex was isolated by Trizol
reagent. Secondly, RNA was quantified by measuring the
optical density at 260/280 nm, and adjusted RNA
concentration of each sample to 50 ng/μL. The SYBR®
green DNA PCR Master Mix (Fermentas, Ottawa,
Canada) was used for the real-time PCR analysis. The
nucleotide sequences of primers used in this experiment
were designed according to the sequence described as
follows:
TLR2 (F: AAGTAGAAACGGTAACAATACGGAG; R:
GTCGGGCATAGGCTGAAAAC, 368 bp);
TLR4 (F: AAAACCTAAGGAGAGGAGGCTAA;
R: AAAAAAAGAAACTGACAGAAAATGG, 248 bp);
IRAK4 (F: GCACGAGAAGAAAAACAGACGG; R:
ACAAACGCAAACAATAGGCAAG, 170 bp);
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GAACTGTGCAGACTCAAA CTCCA, 95 bp);
GAPDH (F: ACGGCAAGTTCAACGGCACAG; R:
GACGCC AGTAGACTCCACGACA, 146 bp)(Ok). Rela-
tive abundance of mRNA was calculated after norma-
lization to glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) RNA. The relative quantification was deter-
mined using the comparative CT method [18].
Western blotting
At 48 hours post reperfusion, the tissues from infarcted
cortex of four rats in each group were homogenized
using a total protein extraction kit (Beyotime Institute of
Biotechnology, Nanjing, China). The homogenates were
then centrifuged at 10,000 g for ten minutes at 4°C, and
the protein concentration of the supernatants was mea-
sured. Western blot analysis was conducted with 10%
sodium dodecyl sulfate-polyacrylamide gel electrophor-
esis (SDS-PAGE). Four samples (from four different rats)
in every experimental group were used for statistical
analysis. After electrophoresis, proteins were transferred
onto PVDF membranes (Millipore Corporation, Billerica,
USA). The membranes were probed with anti-TLR4
(1:1,000, Boster Biotechnology Company, Wuhan, China),
anti-TLR2 (1:1,000, Epitomics), anti-IRAK4 (1:1,000, Cell
signaling), anti-IL-1β (1:1,000, Proteintech), anti-β-actin
(1:2,000, Proteintech). The membranes were then in-
cubated with goat anti-rabbit horseradish peroxidase-
conjugated secondary antibody (1:5,000) for one hour
at room temperature. The blots were developed with
the enhanced chemiluminescence (ECL) detection method,
and the relative density of bands was analyzed with
a chemiluminescence system (Bio-Rad Laboratories,
Philadelphia, USA).
Statistical analyses
All data are expressed as mean ± SD and are suitable for
analysis using nonparametric tests. The Kolmogorov-
Smirnov test was applied to test for a normal distribu-
tion. The means of the different groups were compared
by a one-way ANOVA Student-Newman-Keuls test. Sig-
nificant differences were accepted when probability
values were < 0.05.
Results
Ischemic postconditioning protected ischemia/
reperfusion-induced brain damage, cerebral edema and
neurological dysfunction
Despite the report that ischemic postconditioning pro-
tected 2 hour focal ischemia-induced brain damaged at 48
hours post reperfusion [19], it remains unclear whether
ischemic postconditioning confers protection on brain
damage caused by longer duration of ischemia. Thus, wecompared the effect of ischemic postconditioning on brain
damaged induced by focal ischemia ofvarying duration.
As shown in Figure 1, no significant difference was
found between the volume of cerebral infarction pro-
duced by 23, 4.5 and 6 hours of ischemia. Ischemic post-
conditioning attenuated markedly the infarction size
caused by 2 and 3 hours of ischemia, but not by 4.5 or 6
hours of ischemia. Further, we shortened the ischemia
time to 4 hours and found ischemic postconditioning
also suppressed significantly the cerebral infarction.
Therefore, our results suggest that ischemic postcondi-
tioning confers protection on cerebral infarction caused
by ischemia not longer than four hours.
Moreover, consistent with the findings regarding cere-
bral infarction, neurological dysfunction and cerebrale-
dema caused by 2, 3 and 4 hours of ischemia were all
attenuated markedly by ischemic postconditioning treat-
ment, whereas no significant changes could be found in
the 4.5 and 6 hour ischemia groups (Figure 2). Thus, our
results indicated that administration of ischemic postcon-
ditioning benefits brain damage caused by focal ischemia
not longer than four hours.
In order to explain why ischemic postconditioning
could not protect brain damage caused by 4.5 hours
ischemia, we investigated the potential mechanism in
the subsequent studies by comparing the differences
produced by ischemia postconditioning between the rats
insulted by 4.5 hours and 2 hours of ischemia.
Ischemic postconditioning attenuated ischemia/
reperfusion-induced apoptosis
Apoptosis has been found to be an important death
mode of neurons during the course of ischemia and
reperfusion. We thus compared the difference in the
apoptotic ratio between the 2 hour ischemia group and
the 4.5 hour ischemia group by using flow cytometry.
Our results showed that, despite no significant difference
being found in the apoptosis ratio between the 2 hour
and 4.5 hour ischemia group, ischemic postconditioning
markedly reduced 2 hour ischemia-induced apoptosis,
while there was no difference in the apoptosis ratio
between the 4.5 hour ischemia and ischemic postcon-
ditioning group (Figure 3). This indicated that the
protection of ischemic postconditioning was related
to inhibition of apoptosis induced by ischemia and
reperfusion.
Ischemic postconditioning suppressed the transcription
and expression of toxic inflammatory cytokine IL-1β
Accumulating evidence has shown that inflammation
plays an important role in modulating cerebral injury
and apoptosis caused by ischemia/reperfusion [20,21];
we thus examined the effects of ischemic postcondition-
ing on the production of neurotoxic cytokine IL-1β. As
Figure 1 Protection of ischemic postconditioning on cerebral infarction. (A) Images of TTC staining. (B) Statistical analysis of infarction
volume; (n = 6 in each group).
Figure 2 Protective effect of ischemic postconditioning on cerebral edema and neurological function. (A) Statistics of cerebral edema.
(B) Statistics of neurological scores; (n = 6 in each group).
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Figure 3 Changes in the apoptosis between 2 hour and 4.5 hour ischemia groups treated with or without ischemic postconditioning.
(A) Representative image of flow cytometry with doubling staining with dUTP- FITC and propidium iodide (PI); (B) Statistical analysis of apoptotic
rates; (n = 4 in each group).
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group, either the expressional or the transcriptional level
of IL-1β increased significantly in both the 2 hour ische-
mia group and the 4.5 hour ischemia group. However,
ischemic postconditioning only suppressed markedly the
elevation of IL-1β in the transcriptional and expressional
levels caused by 2 hour ischemia. Thus, this indicated
that the protection of ischemic postconditioning is asso-
ciated with its inhibition of the production of neurotoxic
cytokine IL-1β.Figure 4 The effect of ischemic postconditioning on the transcription
ischemia groups. (A) Statistics of the transcriptional levels of IL-1β. (B) Rep
expressional level of IL-1β; (n = 4 in each group).Ischemic postconditioning inhibited the transcription and
expression of TLR2 and TLR4
Since previous reports showed that the production of
IL-1β is associated with TLR2 and TLR4 pathway [8], we
thus speculated that the inhibitory effect of ischemic
postconditioning on the IL-1β production might be cor-
related with inhibition of TLR2 or TLR4 pathway.
As shown in Figure 5A and B and Figure 6A and B,
immunohistochemistry showed that there were signifi-
cantly more TLR2 or TLR4 positive staining cells in theand expression of IL-1β between the 2 hour and 4.5 hour
resentative Western blotting images of IL-1β. (C) Statistics of the
Figure 5 The effect of ischemic postconditioning on TLR2 between 2 hour and 4.5 hour ischemia groups. (A) Representative images of
cells with positive immunochemical staining to TLR2, scale bar = 50 μm. (B) Statistics of the number of cells stained with TLR2. (C) Statistics of
the transcriptional levels of TLR2. (D) Representative Western blotting images of TLR2. (E) Statistics of the expressional level of TLR2. (F) Representative
images under confocal microscope in the sham group. (G) Representative images under confocal microscope in the ischemia group;
(n = 4 in each group).
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group. When ischemic postconditioning was adminis-
tered, TLR2 or TLR4 positive staining cells reduced
markedly in the 2 hour ischemia group, but not in the
4.5 hour ischemia group. Since cortex contains neurons,
astroglia and microglia, all of which are thought to be
related to the inflammatory response [8], we used laser
confocal microscopy in combination with immunohisto-
chemical double staining to examine the location of
TLR2 and TLR4 within these cells. Meanwhile, NeuN
was used for detecting neurons, GFAP for astroglia and
Lectin for microglia. As shown in Figures 5F and G and
6F and G, despite lower expression of TLR2 and TLR4
in the sham group, TLR2 and TLR4 were observed to be
located in neurons, as well as in astroglia and microglia
in the ischemia group, indicating that neurons, astroglia
and microglia participate in the inflammatory response
caused by ischemia and reperfusion.Further, RT-PCR and Western blotting were used to
analyze the changes in transcription and expression of
TLR2 and TLR4. We found ischemic postconditioning
inhibited effectively the 2 hour ischemia-induced in-
crease of TLR2 and TLR4 in transcriptional level
(Figure 5B and Figure 6B). Moreover, the higher pro-
tein levels of TLR2 and TLR4 caused by 2 hour ische-
mia were also inhibited. By contrast, when ischemia time
was prolonged to 4.5 hours, no significant difference
could be found in the transcription and expression of
both TLR2 and TLR4 between the rats treated with
or without ischemic postconditioning (Figures 5C and D,
and 6C and D).
Therefore, our results indicated that the protection of
ischemic postconditioning on brain damage caused by 2
hour ischemia/reperfusion at 48 hours is correlated with
suppression of the transcription and expression of TLR2
and TLR4.
Figure 6 The effect of ischemic postconditioning on TLR4 between 2 hour and 4.5 hour ischemia groups. (A) Representative images of
cells with positive immunochemical staining to TLR4, scale bar = 50 μm. (B) Statistics of the number of cells stained with TLR4. (C) Statistics of the
transcriptional levels of TLR4. (D) Representative Western blotting images of TLR4. (E) Statistics of the expressional level of TLR4. (F) Representative
images under confocal microscope in the sham group. (G) Representative images under confocal microscope in the ischemia group;
(n = 4 in each group).
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IRAK4 (interleukin-1 receptor-associated kinase 4) is a
key molecule responsible for relaying signals from TLR2
or TLR4 to NF-κB that would initiate the production of
inflammatory cytokines such as IL-1β [22]; we thus com-
pared the changes of IRAK4 transcription and expres-
sion between the rats treated with or without ischemic
postconditioning. As shown in Figure 7, despite 2 hours
of ischemia and 4.5 hours of ischemia leading to obvious
elevation in the transcriptional and expressional level of
IRAK4, only 2 hour ischemia-induced changes in IRAK4
was inhibited effectively by ischemic postconditioning.
No significant influence of ischemic postconditioning on
IRAK4 was found in the 4.5 hour ischemia group. Thus,
this result suggested that ischemic postconditioning
mitigated the transmission of inflammatory signal from
TLR2 or TLR4 via inhibition of IRAK4.Discussion
The present study showed that five cycles of ten seconds
reperfusion and ten seconds ischemia was an effective
ischemic postconditioning procedure to suppress is-
chemia/reperfusion-induced cerebral infarction, cellu-
lar apoptosis and cerebral edema. Moreover, we found
ischemic postconditioning exerted protection when ische-
mic period was not longer than four hours. The protective
effect of ischemic postconditioning was associated with
inhibition of neuroinflammation via alleviating the tran-
scription and expression of IRAK4, TLR2 and TLR4, and
attenuating the production of neurotoxic cytokine IL-1β.
Intra-arterial thrombolysis via interventional neurora-
diology is an important strategy to treat the patients
with cerebral artery thrombosis, but reperfusion-induced
cerebral damage is the key issues influencing the thera-
peutic effect. For the patient without the finding of
cerebral infarction on computer tomography (CT) images,
Figure 7 Changes in the IRAK4 between 2 hour and 4.5 hour ischemia groups treated with or without ischemic postconditioning.
(A) Statistics of the transcriptional levels of IRAK4. (B) Representative Western blotting images of IRAK4. (C) Statistics of the expressional level of
IRAK4; (n = 4 in each group).
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is often used as a criterion to decide whether intra-arterial
thrombolysis could be performed [23]. Since animal stud-
ies and clinical trials have shown ischemic postcondition-
ing could inhibit reperfusion-induced tissue damage
[19,24,25], clarifying its effects on brain damage caused by
various duration of ischemia would benefit its potential
administration in future clinical practice. In this study, our
results showed that ischemic postconditioning conferred
no protection on brain damage secondary to 6 or 4.5 hour
ischemia, but protected infarct volume, cerebral edema
and neurological dysfunction caused by ischemia of 4
hours or less duration. This indicated that the protection
of ischemic postconditioning would be effective for 4
hours ischemic damage.
According to the time of being performed, ischemic
postconditioning is classified into immediate postcondi-
tioning performed at the end of ischemia, and delayed
postconditioning that is administered when blood supply
has been recovered for a while. Immediate and delayed
postconditioning are both proved to be protective to
ischemia/reperfusion-induced brain damage, but the pro-
tective effect of immediate postconditioning is better than
that of delayed postconditioning [15]. Thus, we chose to
use immediate ischemic postconditioning in this study.
Additionally, various ischemic postconditioning proce-
dures consisting of different cycles of ischemia and reper-
fusion time were investigated in previous studies. It has
been found that three cycles of 30 seconds reperfusionand 30 seconds ischemia [26], 5 minutes reperfusion and
5 minutes ischemia [27], and 30 seconds reperfusion and
10 seconds of ischemia [28] were all effective in alle-
viating brain damage caused by ischemia/reperfusion.
Our study demonstrated that five cycles of ten seconds
reperfusion and ten seconds ischemia is an effective
ischemic postconditioning procedure to attenuate reper-
fusion-induced cerebral infarction, cerebral edema and
neurological dysfunction.
To date, the protective mechanism underlying ische-
mic postconditioning has been investigated widely and is
found to be related to multiple factors including sup-
pression of oxidative stress, inhibition of endoplasmic
stress and attenuation of apoptosis [14,19,29-31]. In this
study, we found ischemic postconditioning attenuated
apoptosis in the 2 hour ischemia group but not in
4.5 hour ischemia group, which could partly explain the
differences in the protection generated by ischemic post-
conditioning between the 2 hour ischemia group and
4.5 hour ischemia group. Despite not having examined
the occurrence of apoptosis in neurons or glial cells or
investigating its potential mechanism, a previous study
has shown that inflammatory cytokines are crucial
inducers leading to apoptosis in both neurons and
glial cells [32]. Moreover, ischemic postconditioning
has been demonstrated to inhibit inflammation via
activation of Akt-eNOS-NO-HIF pathway [14], down-
regulation of the expression of Egr-1 (early growth
response-1) and RGMa (repulsive guidance molecule A)
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[33], and blocking the increases of microglia, macro-
phages, CD4 T cells and CD8 T cells as well as B lympho-
cytes in damaged tissue [11]. However, it is still unclear
whether the inhibitory effect of ischemic postconditioning
on inflammation is via modulating TLRs.
IL-1β is an interesting neurotoxic cytokine possessing
autocrine-like function and promotes its own secretion
under ischemic stimuli, which directly induces neuronal
apoptosis and enhances the expression of chemokines
within microglia and astrocyte [8]. It was reported previ-
ously that ischemic postconditioning could inhibit the
production of neurotoxic cytokines IL-1β, as well as IL-
6, IL-8 and TNF-α [13,15]. Our study showed that ische-
mic postconditioning inhibited the production IL-1β in
the 2 hour ischemia group, not in 4.5 hour ischemia
group, which might be the reason underlying the differ-
ential protection of ischemic postconditioning between
the 2 hour ischemia group and 4.5 hour ischemia group.
Given that TLR2 and TLR4 play an active role in
modulating the production of neurotoxic cytokines dur-
ing the course of brain damage caused by ischemia and
reperfusion [34], we also comparedthe changes in TLR2
and TLR4 between the 2 and 4.5 hour ischemia group
when ischemic postconditioning was administered. Our
results showed that ischemic postconditioning not only
inhibited 2 hour ischemia-induced abnormal transcrip-
tion and expression of TLR2 and TLR4, but also sup-
pressed the transcription and expression of IRAK4, a
protein mediating signals from TLR2 or TLR4 to NF-κB
to initiate the transcription of IL-1β [22,35]. Similarly, at-
tenuation of inflammation by inhibition of TLR2, TLR4
and IRAK4 has also been reportedby other researchers.
Ziegler et al. reported that blocking TLR2 protected
against accumulation of inflammatory cells and neuronal
injury in experimental stroke [36]. Yao et al. found that
neutralization of TLR4 in primary cultured microglia
attenuated hypoxia-induced expression of TNF-α and IL-
1β in BV-2 cells [37]. Wang et al. revealed that IRAK4
knockout mice were severely impaired in signaling and
cellular responses to IL-1, IL-18, and most TLR ligands
[22]. Therefore, we think that the protection of ischemic
postconditioning on ischemia/reperfusion-induced brain
damage is closely associated with inhibition of neuroin-
flammation via down-regulation of the transcription and
expression of IRAK4, TLR2 and TLR4.
In conclusion, we demonstrate in this study that is-
chemic postconditioning is effective up to 4 hours
after ischemia. The protection of ischemic postcon-
ditioning on ischemia/reperfusion-induced cerebral in-
farction, cerebral edema and neurological dysfunction
is associated with its attenuation of apoptosis, and in-
hibition of neuroinflammation via modulation of the
TLR2 and TLR4 pathways.Abbreviations
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